RE:RE:RE:RE:RE:Takeover/BuyoutNot that I put much stock in a changing administration or new head of the FDA in such a short time frame like we are in for BTD but the new head of the FDA, Dr. Marty Makary, is said to favor disruptive innovation so that can't be a bad thing for us especially with so much that lies ahead for TLT.
DeathXray33 wrote: O12009 wrote: One thing I do know is $2 is not even a thought. Merck shares or what ever. With all that is in the pipeline the low ball bid is 8 billion. We are getting closer each day and when we start our trial for brain and lung cancer we should have BTD and on the way for AA for bladder. The many vaccines we could be getting an upfront payment along with royalties by itself is worth far more than $2.
"Disruptive innovations tend to be produced by outsiders and entrepreneurs in startups, rather than existing market-leading companies. The business environment of market leaders does not allow them to pursue disruptive innovations when they first arise, because they are not profitable enough at first and because their development can take scarce resources away from sustaining innovations (which are needed to compete against current competition).[5] Small teams are more likely to create disruptive innovations than large teams.[6] A disruptive process can take longer to develop than by the conventional approach and the risk associated with it is higher than the other more incremental, architectural or evolutionary forms of innovations, but once it is deployed in the market, it achieves a much faster penetration and higher degree of impact on the established markets."